Newpong's Expansion into Middle Eastern Aesthetic Medical Market

Newpong participated in the 'World Health Expo (WHX) Dubai 2026,' held from February 9 to 12 at the Dubai Exhibition Centre in the United Arab Emirates. By showcasing its flagship products, the company has officially ramped up its expansion into the Middle Eastern premium aesthetic medical market.

As the successor to ‘Arab Health,’ World Health Expo (WHX) Dubai is the largest healthcare industry platform in the MENA (Middle East and North Africa) region. It serves as a strategic exhibition where medical decision-makers, specialists, and global distributors from around the world gather. According to the organizers, this year’s event featured over 5,000 participating companies from more than 180 countries.

At Hall South 5, Booth A70, Newpong showcased its comprehensive ultrasound portfolio spanning surgery, aesthetics, and therapy. The lineup featured the 'LSSA,' a minimally invasive ultrasound-assisted liposuction device; the 'Lincurve Pro,' a next-generation High-Intensity Focused Ultrasound (HIFU) system; and 'SonoCare,' a therapeutic ultrasound stimulator.

■Enhanced Precision and Safety with the World’s Smallest Diameter Probe

According to Newpong, the LSSA garnered the most significant attention at the exhibition. The LSSA is a minimally invasive ultrasound-assisted liposuction device equipped with an ultra-thin 0.9mm diameter probe. It is specifically designed for application in delicate anatomical areas—such as the double chin, accessory breasts, and calves—which were previously difficult to access with conventional equipment.

The core technology behind the device is the ‘Deep Sono Algorithm,’ independently developed by Newpong. This technology detects frequencies in real-time during procedures, maintaining a constant power output regardless of changes in tissue characteristics. It ensures uniform energy delivery irrespective of variations in the density or moisture content of adipose tissue, thereby enhancing both the safety and reproducibility of the procedure.

Industry experts agree that a thinner probe diameter is advantageous for minimizing damage to surrounding tissues and shortening recovery time. Analysis suggests that the LSSA is positioned to demonstrate a distinct competitive edge, particularly as the demand for minimally invasive procedures is rapidly expanding in the Middle Eastern market.

■Leading Innovation with the World’s First Design Contoured to Facial Curvature

The Lincurve Pro, also showcased by Newpong at this exhibition, is a third-generation High-Intensity Focused Ultrasound (HIFU) device featuring a core "Concave Cartridge" designed to match facial contours. By improving skin adhesion compared to conventional flat cartridges, it induces more precise thermal coagulation in the subcutaneous fat layer and the Superficial Muscular Aponeurotic System (SMAS). Newpong explained that the Lincurve Pro is a strategic product targeting the high-end dermatology and plastic surgery clinic markets in the Middle East.

■Imminent Partnership Negotiations with Key Middle Eastern Nations

During the exhibition, Newpong conducted strategic market analysis meetings with major distributors and medical institutions across the Middle East. The company reported entering detailed partnership discussions with several countries. However, it has withheld confirmation regarding specific cooperation outcomes, such as the finalization of contracts.

The greatest strength of LSSA is its 0.9mm ultra-thin probe structure, which reduces the risk of side effects and allows for relatively seamless procedures in areas that were previously difficult to access,” said Jay Lee, CEO of Newpong. “With World Health Expo Dubai as a turning point, we are committed to firmly establishing our global reputation as a leader specialized in minimally invasive ultrasound medical devices.

He added, “Newpong aims for a business model that goes beyond merely supplying equipment to one that grows alongside our partners in each country. Using the Middle East as a strategic bridgehead, we will progressively expand the presence of our ultrasound-based precision medical devices in the global aesthetic and plastic surgery markets.”

Meanwhile, Newpong is a specialized ultrasound medical and aesthetic device company founded on the philosophy of "delivering happiness through creative thinking based on 'Why'." With a flagship lineup including the Lincurve Pro (HIFU), LSSA (minimally invasive ultrasound liposuction), and SonoCare (therapeutic ultrasound), the company continues to advance its technology through DeepSono Lab, its in-house R&D center focused on clinical-driven innovation.